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Abstract 
 
Background: Tragia belongs to the family Euphorbiaceae which contains about 152 species. Interestingly, most of the 
earlier investigations have been done using only five Tragia species, namely, Tragia involucrata, Tragia cannabina, 
Tragia spathulata, Tragia plukenetii, and Tragia benthamii. The objective of the present review is to compile the 
phytochemical, pharmacological and biological studies of the selected five Tragia species reported in the literature.     
Methods: The reported data/information was retrieved mainly from the online databases of PubMed (MEDLINE), 
EMBASE and Botanical Survey of India. 
Results: The present review elaborated the phytochemical, pharmacological and biological properties of the selected 
five Tragia species obtained from recent literature.  
Conclusion: This review provides a basis for future investigation of Tragia species and, especially for those species 
that have not been explored for biological and pharmacological activities. 
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Introduction   
 
Herbs having medicinal properties are commonly used as herbal tonics which mostly contain peppermint, 
ginger, garlic, nettles, lemon, balm etc. (Winston and Nvwoti, 1992). According to the Dietary Supplement Health and 
Education Act, 1994 of the US, herbal medicines are classified as food supplements (Klepser and Klepser, 1999). 
Herbal medicines are used in daily life to treat a simple common ailment to life threatening diseases. The Indian 
subcontinent and Africa have long been recognized as an herbal hub and a variety of herbal medicines in different 
formulations have been used for several years. Furthermore, ancient India had given divine Vedas (Rigveda, Yajurveda, 
and Atharvaveda) and Samhitas (Charak Samhita and Sushrut Samhita) which describes the medicinal properties and 
uses of many herbal species. Kushagara et al., (2011) conducted a study about different health care systems practiced in 
India on 492 people. The outcome of this study revealed that Ayurveda, allopathy and homeopathy were practiced in 
41, 31 and 28% of the studied population respectively. Increasing population size, drugs insufficiency, higher cost, 
severe adverse effects and ineffectiveness of many allopathic drugs, escort to the significance of herbal medicines to 
combat many diseases (Panda et al., 2012).  Most of the drugs available in the market are mainly isolated from the herb 
source. For example, vincristine, vinblastine from Catharanthus roseus, podophyllotoxin from rhizomes of 
Phodophyllum species, palcitaxol from Taxus brevifolia used in cancer chemotherapy, digitoxin from the Digitalis 
purpurea in cardio protective therapy, caffeine from Camellia sinensis, codeine and morphine from the Papaver 
somniferum for central nervous system activities (Moss et al., 2006).  
India and Africa are enriched with a variety of different species of medicinal plants, however, many plant 
species are not fully explored. Tragia, one among the plant species has to be further explored by the scientific 
community.   People from the folklore have been using Tragia species to treat variety of ailments since many years ago 
Recently, an increasing attention has been drawn to Tragia species because of the identification of multiple bioactive 
phytoconstituents and their numerous biological and pharmacological activities.  The focus of this short review is to 
elaborate the total phytochemical constituents and pharmacological activities reported for the selected species of 
Tragia. The reported data were retrieved up to November 2016 mainly from online databases PubMed (Medline) and 
EMBASE by using the key word, ‘Tragia’ which resulted in 21 and 58 results respectively. For additional information, 
Botanical survey of India database was referred.     
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Taxonomy 
Kingdom:  Plantae 
Phylum:  Mangoleophyta 
Class:   Mangoliopsida 
Order:   Malpighiales 
Family:   Euphorbiaceae 
Genus:   Tragia 
Species:  T. involucrata, T. cannabina, T. spathulata, T. plukenetii, and T. benthamii 
      
Worldwide distribution of Tragia species: Somalia, Ehiopia, Kenya, India, and Tanzania 
 
Tragia involucrata 
 
T. involucrata is a shrub, widely distributed in the Indian subcontinent and grows in dry land weed. It is  found 
to have enormous medicinal properties and have been used by the Malaiyali tribes of Western Ghats of India. The 
preliminary phytochemical screening results revealed the presence of alkaloids, carbohydrates, protein,  tannins, 
flavonoids, sterols and saponins in the different extracts of T. involucrata (Table 1) (Dash et al., 2000). Several 
colorless phytocompounds have been isolated and characterized from T. involucrata such as vinyl hexylether, shellsol, 
2,4-dimethyl hexane, 2-methylnanone, and 2,6-dimethyl heptane. In addition, five other different compounds, namely; 
TIR-01, TIR-02, TIR-03, TIR-04 and TIR-05 has been identified in the ethyl acetate extract of T. involucrata as shown 
in figure 1 (Panda et al., 2012).  
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Figure 1: Structures resulted from the ethyl acetate extract of Tragia. involucrata (Panda et al., 2012). 
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Table 1: List of phytochemical constituents of Tragia species 
Tragia Species 
 
Parts of 
plants used Extract 
Phytochemical constituents  
Reference 
Alkaloid Glycoside Reducing sugar Tannin Protein Flavonoid Sterols Saponin 
T. involucrata 
Leaf Ethanol + + - - - + + - Sathish, 2013 
 
 
 
 
 
Root 
Petroleum 
ether - - - - - - + - 
Dash et al., 2000 
Chloroform + - - - - - + - 
Ethyl acetate + - - - - - - - 
Methanol - - + + - + - + 
Water - - + + + + - + 
T. cannabina 
 
Whole 
plant 
Chloroform - - - + - + + - 
Raju, 2012 Methanol + - - + - - - - 
T. spathulata  
 
Leaf 
 
Ethanol + + - - - - - - 
Ogundare and 
Olorunfemi, 2007 
Methanol + + - - - - - - 
Acetone + + - - - - - - 
T. plukenetii  Leaf Ethanol + + - + - + + + Daniel, 1991 
 
T. benthamii 
 
Whole 
plant 
Ethanol + - + + - - - + Oladosu et al., 2013 
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T. involucrata leaf has been traditionally used to treat inflammation, wounds, eczema, scabies and skin 
infections. It has also been found to be effective in treating pain and bronchitis (Kirtikar and Basu, 1987). The T. 
involucrata root has been traditionally used for the treatment of high fever. It reduces the elevated body temperature to 
normal by its diaphoretic action. Besides, the antimicrobial activity of T. involucrata root/leaf extracts have been 
reported against P. vulgaris, E. coli, (Gram-negative bacteria) and S. aureus (Gram-positive bacteria) with disc 
diffusion techniques (Gopalakrishnan et al., 2006, Sathish et al., 2013). Recently, the methanolic extract T. involucrata 
has been found to be very effective in treating foot ulcer pathogens obtained from diabetic patients (Subbu Lakshmi et 
al., 2016). 
Acute oral toxicity studies in mice revealed that the methanolic extract of root/leaf was found to be safe with 
doses up to 2000 mg/kg (Dhara et al., 2000). The methanolic extract of root/leaf of T. involucrata has also been 
reported for anti-inflammatory activity in carrageenan-induced rat paw edema model.  Similarly, the anti-inflammatory 
activity of the methanolic extract of root/leaf of T. involucrata was further confirmed by cotton pellet granuloma 
technique. In addition, the same author reported the analgesic activity of root/leaf of T. involucrata and postulated that 
the analgesic activity of T. involucrata was mediated by the inhibition of prostaglandins sensitized pain receptors at the 
inflammatory site (Dhara et al., 2000). Recently, root extracts of T. involucrata have been reported for hepatoprotective 
activity against CCl4 –induced hepatotoxicity in rats (Alanazi et al., 2015). Moreover, ethanolic leaf extract of T. 
involucrata exhibited a significant antibacterial activity against opportunistic pathogens namely E. coli, S. aureus, P. 
mirabilis and S. marcescens isolated from clinical cases of suspected symptomatic HIV/AIDS patients. (Xavier et al., 
2015). Recently, Sulaiman and Balachandran (2016) evaluated for antioxidant potential of butanolic fractions (Fr B1, 
Fr B2, Fr B3, Fr B4 and Fr B5) of T. involucrata aqueous-methanolic extract using in vitro DPPH radical scavenging 
assay. Their findings revealed that the fractions (Fr B3 and Fr B4) exhibited significant free radical scavenging activity 
with EC50 of 4.58 and 4.26 µg/ml respectively. It has been further confirmed the presence of flavonoids such as iridin, 
dihexosyl quercetin, quercetin-3-O-rutinoside, rhamnosyl hexosyl methyl quercetin, gentenstein 7-glucoside for FrB3 
and orientin, C-(O-caffeoyl-hexosyl)-O-hexoside and tricin 7-O-hexosyl-O-hexoside for FrB4 (Sulaiman and 
Balachandran, 2016). The isolated compounds from T. involucrata root has also been reported for antimicrobial and 
wound healing activities.  The isolated compounds from the methanolic extract of T. involucrata root or leaf, shellsol 
and vinyl hexyl ether have been reported for their antimicrobial activity against S. aureus with effective MIC 
(minimum inhibitory concentrations) of 0.182, 0.198 µg/ml, respectively (Gopalakrishnan et al., 2013). Furthermore, 
the shellsol purified from T. involucrata leaf has been studied topically for wound healing activity in rats. The 
percentage of wound healing effect was gradually increased by the shellsol (10g/kg) from 4th to 16th day, but the 
higher wound healing effect was observed on the 20th day (83.2%) and 24th day (88.18%) when compared to the 
vehicle treated control group (only 50% healing). The other compounds isolated from T. involucrata, namely 2-
methylnonane, 2,4-dimethyl hexane and 2,6- dimethyl heptane exerted only a weak activity against the S. aureus and P. 
vulgaris (Gopalakrishnakone et al., 2006b, 2006c) . In another study, the hydrocarbon esters such as shellsol, vinyl 
hexylether, and 2, 4-dimethyl hexane isolated from T. involucrata showed a potent antimicrobial and anti-inflammatory 
activities and suggested that it could be effective to control the growth of certain food-borne and food-spoilage 
pathogens (Samy et al., 2013). Recently, antihistaminic activity of 5-hydroxy-1-methylpiperidin-2-one, an isolated 
phytocompound from the leaf of T. involucrata has been established using in vivo, ex vivo and in silico studies and 
demonstrated the therapeutic potential in treatment of asthma (Alagar Yadav et al., 2015). Farook and Atlee (2011a) 
demonstrated the antidiabetic activity of the alcoholic extract of T. involucrata root/leaf in rats and showed a significant 
decrease in the rate of intestinal glucose absorption thereby resulting in improved glucose tolerance. Administration of 
a single oral dose of 500 mg/kg of aqueous extract of T. involucrata root/leaf (AETI) showed a significant reduction in 
blood glucose level. It has been proposed that the reduced glucose transport, extra pancreatic action or decreased 
activity of glycolytic enzymes could be the possible mechanisms of action of T. invalucrata (Farook and Atlee, 2011a). 
This was further confirmed by a series of enzymatic assays to detect the free radical scavenging property of AETI. 
Lipid peroxidation is commonly observed in streptozotocin (STZ) and nicotinamide (NA) - induced diabetic rats. The 
diabetic animals significantly decreased the antioxidant enzyme levels, such as SOD, CAT, GPx and GSH in liver and 
kidneys (Farook and Atlee, 2011b). The extracts of T. involucrata leaf significantly enhanced these natural antioxidant 
enzymes in diabetic animals and demonstrated the therapeutic potential against diabetes and its associated 
complications (Farook and Atlee, 2011b). Recently, an in vitro study revealed that aqueous, ethyl acetate, and 
chloroform extracts of T. involucrata leaf dose-dependently inhibited α-amylase activity using dinitrosalicylic acid 
(DNS) method and demonstrated for its antidiabetic effect (Vinodhini et al., 2015). In another study, hexane and ethyl 
acetate extracts of aerial parts of the T. involucrata was reported for anticancer activity. This study revealed the 
optimum anticancer activity of these extracts on Ehrlich’s Ascites Carcinoma (EAC) model and demonstrated the 
involvement of antioxidant property of T. involucrata in the anticancer activity (Jayaprasad et al., 2012). A recent study 
by Bhattacharya and Chandra (2014) demonstrated the mosquitocidal activity of T. involucrata root extracts against 
Culex quinquefasciatus (female mosquito) in Phagodeterrence test. In that study, they used different extracts of T. 
involucrata root like chloroform: methanol (1:1 v/v), petroleum ether: ethyl acetate (1:1 v/v), benzene: ethyl acetate 
(1:1 v/v), acetone: absolute alcohol (1:1 v/v). It was found that chloroform: methanol (1:1 v/v) extract showed a 
significant mosquitocidal activity (Bhattacharya and Chandra, 2014). Furthermore, CNS depressant activity of 
methanolic extract of T. involucrata (MTI) leaf was reported using a battery of neuropharmacological studies in rodents 
which demonstrated a significant reduction in spontaneous locomotor activity, a significant potentiation of 
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pentobarbitone-induced sleep, a significant depression of body temperature and suppression of the aggressive behavior 
pattern (Chaudhuri et al., 2002). It has been hypothesized that the CNS depressant activity of MTI could be mediated 
through a GABAA-cascade signalling mechanism similar to mechanism of actions of benzodiazepines like diazepam. 
Similarly, the antiepileptic activity of methanolic leaf extract of T. involucrata Linn. in mouse models of maximal 
electroshock-induced convulsions (MES), pentylenetetrazole (PTZ) and picrotoxin (PTX) -induced convulsions  was 
reported (Ganapathi et al., 2014). These authors also hypothesized that the GABAergic mediated mechanism of the 
methanolic leaf extract of T. involucrata Linn. could be responsible for the antiepileptic activity. Taken together, it has 
been suggested that MTI produced CNS activities mediated through GABAergic mechanism (that is opening of 
chloride channels associated with GABAA receptors).   
 
Tragia cannabina   
 
The vernacular name of T. cannabina, in Tamil is cherukanjuru or Karunchenthatti. Preliminary 
phytochemical analysis revealed the presence of tannins, flavonoids, sterols, and alkaloids in different extracts of T. 
cannabina leaf/root (Table 1). Methanol and chloroform extracts of whole plant of T. cannabina showed anti-
inflammatory activity in Sprague-Dawley rats using carrageenan-induced paw edema model (Raju et al., 2012). This 
study revealed that the percentage inhibition of carrageenan-induced paw edema by methanolic extract (300 mg/kg, 
p.o.) and chloroform extract (300 mg/kg, p.o.) of T. cannabina was found to be 37.5% and 17.05%, respectively, which  
were comparable to the reference drug, ibuprofen (55.69%) (Raju et al., 2012). The sub-acute toxicity studies of 
alcoholic extract of T. cannabina leaf revealed that a dose of 125, 250, and 500 mg/kg body weight every 24 h for 28 
days respectively, did not show any signs of toxicity and mortality in the experimental animals. Surprisingly, it was 
observed that the overall well-being of treated animals was improved by evidence of increasing body weight and higher 
food intake (Patel et al., 2012). Ethanolic extract of T. cannabina leaf at an oral dose of 250 mg/kg, showed remarkable 
antihyperglycemic and antioxidant effects in STZ-induced diabetic rats. This study also confirmed the nontoxic 
properties of the ethanolic extract of T. cannabina leaf (Sivajothi et al., 2007). Moreover, the antidiabetic effect of an 
isolated phytocompound, 4-oxo-4H-pyran-2,6-dicarboxylic acid-bis-[6-methyl-heptyl] ester from T. cannabina have 
been demonstrated using in vitro streptozotocin (STZ) -treated chick embryo and in silico docking studies targeting 
active sites of AMPK (Sivajothi and Dakappa, 2014). 
 
Tragia spathulata  
 
T. spathulata is slender turner, armed with stinging hair. Its leaf relieves symptoms of stomachache, backache 
and also prevents measles in infants (Sofowora, 1982). Phytochemical screening of ethanolic, methanolic and acetone 
leaf extracts of T. spathulata resulted in the presence of alkaloids and glycosides (Table 1). T. spathulata showed 
antibacterial effect against S. aureus, P. mirabilis, K. pneumonia, S. typhi, S. pneumonia, E. coli, C. albicans, A. flavus 
and A. fusarium. It has been postulated that the antimicrobial activity of T. spathulata could be due to the presence of 
alkaloids and glycosides (Ogundare and Olorunfemi, 2007). 
 
Tragia plukenetii 
 
The vernacular names of T. plukenetii R. Smith in Telugu and Marathi are duradagondi and churchuri 
respectively. It is widely distributed in India, Somalia, Ethiopia, Kenya and Tanzania. It has unisexual flowers with 
hairy racemes and 3-lobed-capsules with globose seeds. The leaf is palmately 3-partite, pinnatifid. Traditionally, this 
plant has been used to treat sore throat (Yoganarasimhan, 2000). The medicinal properties of ethanolic extract of T. 
plukenetii leaf  is due to the presence of phytoconstituents like alkaloids, carbohydrates, flavonoids, glycosides, sterols, 
saponins and tannins reported in the literature as shown in Table 1. Flavonoids are widely distributed in T. plukenetii in 
the form of glycosides. Leo Stanley et al. (2012) reported the presence of about 16 miscellaneous compounds in T. 
plukenetii and extracted the steroid (TP-I) and isoquinoline (TP-II) as shown in figure 2. Minor flavonoids aurones 
(sulpheretin), chalcones (butein) and flavanones (naringin), and major flavonoids include quercetin, kaempferol and 
myricetin have also been reported (Leo Stanley et al., 2012). Quercetin helps in reducing aggregation of erythrocytes 
(Daniel, 1991) and in the treatment of capillary fragility. It has been demonstrated for antioxidant and antiulcer 
activities (Parmar and Shikha, 1998). The antitumor activity of T. plukenetii leaf extracts using Ehrlich ascites 
carcinoma (EAC) tumor model have been reported. It has been proposed that antioxidant property of T. plukenetii could 
be involved in its antitumor activity (Meenakshi et al., 2008). Similarly, the contribution of antioxidant property of T. 
plukenetii in its antihyperglycemic effect has been demonstrated by Venkatesh et al. (2014).   
 
 
 
 
 
 
 
Figure 2: Structures resulted from the ethanolic extract of Tragia plukenetii (Leo Stanley et al., 2012). 
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A review by Gupta and Jain (2010) revealed the wound healing effect of the ethanolic extract of T. plukenetii 
in albino rats. In the same review, it has also been described about the wound healing and antimicrobial activities of the 
methanolic extracts of root and leaf of T. plukenetii (Gupta and Jain, 2010). It has been proposed that the presence of 
higher amount of phenols and flavonoids in T. plukenetii could be responsible for its wound healing activity 
(Gopalakrishnakone et al., 2006a; 2006b). Kalaivanan and Jesudass (2012) reported for antipyretic and diuretic 
activities of T. plukenetii leaf extracts. In vivo study using Guinea pig revealed the antiasthmatic effect of T. plukenetii 
leaf extracts. Similarly, an ex vivo study using rabbit jejunum demonstrated antispasmodic activity of T. plukenetii. 
These studies explained that the presence of saponins in the extract could be responsible for its antiasthmatic activity 
(Kalaivanan and Jesudass, 2012).    
The oral administration of T. plukenetii leaf extract was found to be effective in treating gonorrhea and 
tapeworm infestation and other pathogens, thereby treating gastroenteritis and stomachache (Meenakshi et al., 2005). A 
review by Chavre et al. (2010) reported that the seed powder of T. plukenetii with milk is recommended to control the 
blood glucose in diabetic patients. Similarly, the other parts such as root, twigs and leaf are used to treat polio. The root 
has helped out in male impotency (Chavre et al., 2010). On the inhalation of the burnt leaf, elephantiasis can be 
controlled (Chavre et al., 2010). The leaf of T. plukenetii plays a key role in treating uterine complaints and also in 
relieving skin irritation (Leo Stanley et al., 2012, Kirtikar and Basu, 1987, Chandra Kumar et al., 2011). Venkatesh and 
Fatima (2013) evaluated the antinociceptive effect of ethanolic, petroleum ether, chloroform, ethyl acetate and 
butanolic extracts of T. plukenetii leaf. Interestingly, chloroform extract (68.83%) alone produced a significant 
antinociceptive effect which was comparable to the reference drug, aspirin (72.09%). Based on a naloxone interaction 
study, it has been proposed that the possible mechanism of action of T. plukenetii was not mediated through opioid 
receptors, but it could be due to the activation of peripheral receptors (Venkatesh and Fatima, 2013).  
 
Tragia benthamii   
 
Tragia benthamii Baker is widely available in West, Central and Southern Africa. Its root extract is used as an 
abortifacient and to ease the delivery of the child and also used to treat gonorrhoea (Schmelzer and Gurib-Fakim, 
2008). The antimalarial activity of ethanolic extract of T. benthamii against P. berghei (NK-65) was reported and the 
results were comparable to the reference drug, chloroquine (Oladosu et al., 2013). At a recent conference proceeding, it 
has been reported for the therapeutic potential of T. benthamii, one of the Nigerian medicinal plants for the treatment of 
migraine and common headache and suggested that it could be utilized for the development of novel drug discovery in 
the treatment of migraine (Saganuwan, 2014).   Currently, there is only very limited information of T.benthamii about 
its biological and pharmacological actions available. Phytochemical analysis using GC/GC-MS of volatile oil from 
hydro distilled leaf of T. benthamii revealed the presence of caryophyllene, caryophyllene oxide, ethylene glycol mono-
tert-butyl ether and hexahydrofarnesyl acetone. It has been found that the volatile oil from T. benthamii leaf exhibited 
higher free radical scavenging activity (42.4%) than the reference standard, ascorbic acid (13.8%) in the DPPH 
scavenging assay (Olaoye et al., 2016). Therefore, further studies focusing on isolation and characterization of 
bioactive compounds and establishing their biological and pharmacological actions are warranted.  
 
Conclusion 
 
This review provides a basis for the future investigation using Tragia species, especially for those species that 
have not been much explored for isolation and standardization of bioactive compounds, and pharmacological activities. 
Further studies on Tragia species are warranted to identify the active phytoconstituents responsible for various 
biological and pharmacological activities.  
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